IE49496B1 - A 1,4-dihydropyridine derivative,its preparation and pharmaceutical compositions containing it - Google Patents

A 1,4-dihydropyridine derivative,its preparation and pharmaceutical compositions containing it

Info

Publication number
IE49496B1
IE49496B1 IE2445/79A IE244579A IE49496B1 IE 49496 B1 IE49496 B1 IE 49496B1 IE 2445/79 A IE2445/79 A IE 2445/79A IE 244579 A IE244579 A IE 244579A IE 49496 B1 IE49496 B1 IE 49496B1
Authority
IE
Ireland
Prior art keywords
compound
formula
treatment
preparation
pharmaceutical compositions
Prior art date
Application number
IE2445/79A
Other languages
English (en)
Other versions
IE792445L (en
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Priority to IE1165/83A priority Critical patent/IE49497B1/en
Publication of IE792445L publication Critical patent/IE792445L/xx
Publication of IE49496B1 publication Critical patent/IE49496B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
IE2445/79A 1978-12-18 1979-12-17 A 1,4-dihydropyridine derivative,its preparation and pharmaceutical compositions containing it IE49496B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IE1165/83A IE49497B1 (en) 1978-12-18 1979-12-17 1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1283578A CH639659A5 (de) 1978-12-18 1978-12-18 Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.

Publications (2)

Publication Number Publication Date
IE792445L IE792445L (en) 1980-06-18
IE49496B1 true IE49496B1 (en) 1985-10-16

Family

ID=4386824

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2445/79A IE49496B1 (en) 1978-12-18 1979-12-17 A 1,4-dihydropyridine derivative,its preparation and pharmaceutical compositions containing it

Country Status (18)

Country Link
JP (1) JPS5583783A (enrdf_load_stackoverflow)
AU (1) AU536055B2 (enrdf_load_stackoverflow)
BE (1) BE880591A (enrdf_load_stackoverflow)
CH (1) CH639659A5 (enrdf_load_stackoverflow)
CY (1) CY1321A (enrdf_load_stackoverflow)
DE (1) DE2949491A1 (enrdf_load_stackoverflow)
FR (1) FR2444681A1 (enrdf_load_stackoverflow)
GB (2) GB2037766B (enrdf_load_stackoverflow)
HK (1) HK16086A (enrdf_load_stackoverflow)
IE (1) IE49496B1 (enrdf_load_stackoverflow)
IT (1) IT1164097B (enrdf_load_stackoverflow)
KE (1) KE3593A (enrdf_load_stackoverflow)
MY (1) MY8500130A (enrdf_load_stackoverflow)
NL (2) NL193066C (enrdf_load_stackoverflow)
NZ (1) NZ192422A (enrdf_load_stackoverflow)
SE (1) SE445219B (enrdf_load_stackoverflow)
SG (1) SG97585G (enrdf_load_stackoverflow)
ZA (1) ZA796842B (enrdf_load_stackoverflow)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3022030A1 (de) * 1980-06-12 1981-12-17 Bayer Ag, 5090 Leverkusen 4-thiazol- bzw. 4-imidazol-substituierte, 1,4-dihydropyridine, verfahren zu deren herstellung sowie diese enthaltende arzneimittel
CH655658B (enrdf_load_stackoverflow) * 1980-09-18 1986-05-15
DE3269219D1 (en) * 1981-11-17 1986-03-27 Fisons Plc Dihydropyridines, methods for their production and their formulation and use as pharmaceuticals
ZA83959B (en) * 1982-03-10 1984-09-26 Sandoz Ltd 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
US4414213A (en) * 1982-03-22 1983-11-08 Mead Johnson & Company Dihydropyridyl cyclic imidate esters and their pharmaceutical use
FR2528431B1 (fr) * 1982-06-15 1986-01-10 Sandoz Sa Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments
IL68975A (en) * 1982-06-15 1987-01-30 Sandoz Ag 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydropyridine-3,5-dicarboxylic acid ester derivatives in optically active form,their preparation and pharmaceutical compositions containing them
JPS5978186A (ja) * 1982-10-27 1984-05-04 Yoshitomi Pharmaceut Ind Ltd １，４−ジヒドロピリジン−３，５−ジカルボン酸エステル誘導体
US4794111A (en) * 1984-05-23 1988-12-27 Bayer Aktiengesellschaft Dihydropyridine preparations containing β-blockers
NL194389C (nl) * 1984-06-14 2002-03-04 Novartis Ag Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager.
US5260321A (en) * 1984-11-12 1993-11-09 Sandoz Ltd. Use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins
NL194822C (nl) * 1985-10-01 2003-04-03 Novartis Ag Preparaat voor orale toediening met geregelde afgifte en werkwijze voor de bereiding ervan.
DE3542794A1 (de) * 1985-12-04 1987-06-11 Bayer Ag Antihypertensives kombinationspraeparat
GB8626217D0 (en) * 1986-11-03 1986-12-03 Sandoz Ltd Pharmaceutical compositions
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
KR940003492B1 (ko) * 1988-10-27 1994-04-23 주식회사 유한양행 1,4-디하이드로피리딘유도체 및 그의 제조방법
DE4222770A1 (de) * 1992-07-10 1994-01-13 Bayer Ag Lichtaktivierbare 1-(2-Nitrobenzyl)-substituierte 1,4-Dihydropyridine
JP4625637B2 (ja) 2002-02-22 2011-02-02 シャイア エルエルシー 活性物質送達系及び活性物質を保護し投与する方法
WO2005023787A1 (en) * 2003-09-10 2005-03-17 Shasun Chemicals And Drugs Limited Process for the manufacture of 2,1,3-benzoxadiazole-4-carboxaldehyde
CN103613584B (zh) * 2013-11-27 2016-04-27 沈阳药科大学 一种伊拉地平合成产物后处理的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670824C3 (de) * 1967-03-20 1978-08-03 Bayer Ag, 5090 Leverkusen 1,4-Dihydropyridin-33-dicarbonsäurealkylester
FR2320750A1 (fr) * 1975-08-12 1977-03-11 Hexachimie Dihydro-1,4 pyridines et leur application therapeutique
DE2616991A1 (de) * 1976-04-17 1977-10-27 Bayer Ag Heterocyclisch-substituierte schwefelhaltige dihydropyridine, mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS5373327A (en) * 1976-12-13 1978-06-29 Matsushita Electric Ind Co Ltd Power source system
FI64938C (fi) * 1977-06-20 1984-02-10 Sandoz Ag Foerfarande foer framstaellning av nya terapeutiskt anvaendbara bensoxa- och bensotiadiazolyl-1,4-dihydropyridinderivat

Also Published As

Publication number Publication date
NL193066C (nl) 1998-09-08
HK16086A (en) 1986-03-14
JPH0369910B2 (enrdf_load_stackoverflow) 1991-11-05
DE2949491A1 (de) 1980-06-26
GB2037766B (en) 1983-02-16
NL990014I1 (nl) 1999-07-01
KE3593A (en) 1986-02-07
JPS5583783A (en) 1980-06-24
DE2949491C2 (enrdf_load_stackoverflow) 1988-10-27
GB2103203B (en) 1983-06-08
SE445219B (sv) 1986-06-09
SG97585G (en) 1986-07-18
CH639659A5 (de) 1983-11-30
GB2037766A (en) 1980-07-16
BE880591A (fr) 1980-06-13
AU536055B2 (en) 1984-04-19
FR2444681A1 (fr) 1980-07-18
NL7909024A (nl) 1980-06-20
ZA796842B (en) 1981-07-29
FR2444681B1 (enrdf_load_stackoverflow) 1982-10-29
SE7910188L (sv) 1980-06-19
IT1164097B (it) 1987-04-08
IT7951095A0 (it) 1979-12-14
NL193066B (nl) 1998-05-06
GB2103203A (en) 1983-02-16
CY1321A (en) 1986-06-27
IE792445L (en) 1980-06-18
NZ192422A (en) 1982-09-14
AU5389679A (en) 1980-06-26
MY8500130A (en) 1985-12-31

Similar Documents

Publication Publication Date Title
IE49496B1 (en) A 1,4-dihydropyridine derivative,its preparation and pharmaceutical compositions containing it
AU721247B2 (en) Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
US4466972A (en) Benzoxadiazoles and benzothiadiazoles, their preparation and pharmaceutical compositions containing them
SK283833B6 (sk) Deriváty benzoxadiazolu, benzotiadiazolu, benzotriazolu a chinoxalínu, spôsob ich prípravy, farmaceutická kompozícia, ktorá ich obsahuje, a ich použitie
EP0000150B1 (en) Dihydropyridine derivatives, process for their production and pharmaceutical compositions containing them.
DK157862B (da) Analogifremgangsmaade til fremstilling af imidazolylphenylamidiner eller farmaceutisk acceptable syreadditionssalte deraf
FR2846657A1 (fr) Nouveaux composes pyridopyrimidinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB2041358A (en) Benzoxadiazoles and benzothiadiazoles
US4937242A (en) 1,4-dihydropyridine derivatives and pharmaceutical composition thereof
US4565816A (en) Piperazine derivatives and pharmaceutical composition containing them
SU1395143A3 (ru) Способ получени производных 1,6-нафтиридина в виде рацематов или энантиомеров,или их кислотно-аддитивных солей
US4180581A (en) N-9,10-dihydrolysergyl-m-aminobenzoic acid amide derivative
JP4422964B2 (ja) ５員複素環誘導体、その製造法及びその医薬としての使用
US3542785A (en) 2-hydroxy-4-aryl-quinolines
EP0220653B1 (en) 3-aminocarbonyl-1,4-dihydropyridine-5-carboxylic acid compounds, process for preparation and use thereof, and pharmaceutical composition containing the same
US4034093A (en) 4(1H)-pyrimidinones
NZ329325A (en) 3- or 4-phthalimido-piperidine-2,6-dione derivatives (thalidomides)
KR840002309B1 (ko) 구아니딘 화합물의 제조방법
US4389406A (en) Meta-pyrazolylaminotetramisole analogs and their use in pharmaceutical compositions
NO771697L (no) Fremgangsm}te for fremstilling av fysiologisk aktive isotiourinstoffer
IE49497B1 (en) 1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them
US3182063A (en) Substituted 4-thiazolidinones and process therefor
JPH0778062B2 (ja) Ｄ−ノル−７−エルゴリン誘導体、その製法、薬剤組成物及び使用
NZ199437A (en) 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydro-3-methoxycarbonylpyridine-5-carboxylic acid isopropyl ester and pharmaceutical compositions
US3467662A (en) 1-para-chlorophenyl-3-hydrazino - 1,5,6,7,8,8a-hexahydroimidazo(1,5-a)pyridine and process for its preparation

Legal Events

Date Code Title Description
SPCF Request for grant of supplementary protection certificate

Free format text: SPC 58/93:19930628

SPCG Supplementary protection certificate granted

Free format text: SPC 58/93 EXPIRES:20040104

MK9A Patent expired